Fibromuscular dysplasia surgery: Difference between revisions
(Created page with "__NOTOC__ {{Fibromuscular dysplasia}} {{CMG}}; '''Associate Editor-in-Chief:''' Shantanu Sinha, MD,FACC Please help WikiDoc by adding more content here. It's easy! Click ...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fibromuscular dysplasia}} | {{Fibromuscular dysplasia}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
Surgical intervention is not recommended for the management of [disease name]. | |||
OR | |||
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3] | |||
OR | |||
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | |||
OR | |||
The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | |||
OR | |||
Surgery is the mainstay of treatment for [disease or malignancy]. | |||
==Indications== | |||
*Surgical intervention is not recommended for the management of [disease name]. | |||
OR | |||
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either: | |||
**[Indication 1] | |||
**[Indication 2] | |||
**[Indication 3] | |||
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either: | |||
**[Indication 1] | |||
**[Indication 2] | |||
**[Indication 3] | |||
==Surgery== | ==Surgery== | ||
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | |||
OR | |||
*Surgery is the mainstay of treatment for [disease or malignancy]. | |||
==Contraindications== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: (name of the system)]] |
Revision as of 13:06, 25 April 2018
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia surgery On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia surgery |
Risk calculators and risk factors for Fibromuscular dysplasia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].